Mealey's (September 7, 2022, 2:09 PM EDT) -- CHICAGO — A federal district court did not err in dismissing a shareholder’s federal securities law claims in a class action against a medical device maker and certain of its senior executives over their alleged misrepresentations concerning the company’s order backlog because the shareholder failed to sufficiently plead falsity in making its federal securities law claims, a Sixth Circuit U.S. Court of Appeals panel ruled Sept. 1 in affirming....